Clinical Trial Update: Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial assessing sodium zirconium cyclosilicate to reduce pre-dialysis hyperkalemia in Chinese subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2023-03-28